社区老年人生长分化因子15升高与肌少症的关联
该研究在韩国衰弱与老龄化队列中纳入70-84岁社区老年人,横断面分析929人、2年前瞻分析788人。结果显示最高三分位GDF-15(≥1245 pg/mL)与现患肌少症风险升高相关(OR 1.96,95%CI 1.16-3.33),但基线GDF-15水平与2年新发肌少症无显著关联。
要点
- 横断面分析中,最高GDF-15三分位(≥1245 pg/mL)与现患肌少症风险升高相关(OR 1.96,95%CI 1.16-3.33)。
- GDF-15升高与现患肌少症相关,但不能预测2年新发肌少症。
核心结论
- GDF-15升高与社区老年人现患肌少症相关,但无法预测2年随访期间新发肌少症。
研究设计与样本
- 横断面分析纳入929名70-84岁社区老年人,2年前瞻分析纳入788名参与者,数据来自韩国衰弱与老龄化队列研究。
主要发现
- 多因素调整心脏代谢风险和生物学因素后,最高GDF-15三分位(≥1245 pg/mL)相比最低三分位(<885 pg/mL)的肌少症患病比值比为1.96(95%CI 1.16-3.33)。
关键数值与推荐
- 肌少症状态依据亚洲肌少症工作组2019(AWGS-2019)算法判定。
- 四肢骨骼肌量采用双能X线吸收法测量。
- 估算肾小球滤过率<60 mL/min/1.73 m2的参与者被排除。
临床怎么用
- 在社区老年肌少症评估中,GDF-15升高可提示现患肌少症可能性增加,但不宜单独用于预测2年内新发肌少症。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Growth differentiation factor 15 (GDF-15) is associated with disease progression, mitochondrial dysfunction, and mortality. Elevated GDF-15 level was recently reported to be associated with poorer physical performance in healthy adults. However, the association between serum GDF-15 level and sarcopenia in community-dwelling older adults has not been well characterized. METHODS: We conducted cross-sectional (n = 929) and 2-year prospective analyses (n = 788) among participants aged 70-84 years enrolled in the Korean Frailty and Aging Cohort Study. Participants with an estimated glomerular filtration rate of <60 mL/min/1.73 m2 were excluded. Appendicular lean mass was measured using dual-energy x-ray absorptiometry. Sarcopenia status was determined according to the Asian Working Group for Sarcopenia-2019 algorithm. RESULTS: At baseline, 16.6% of the participants had sarcopenia. Median GDF-15 concentration was higher in the sarcopenic group than in the non-sarcopenic group (1221 pg/mL vs 1019 pg/mL, p < .001). In the multivariate analysis adjusted for cardiometabolic risk and biological factors, the highest GDF-15 tertile (≥1245 pg/mL) had an increased likelihood of sarcopenia (odds ratio, 1.96; 95% confidence interval, 1.16-3.33) than the lowest tertile (<885 pg/mL). During the 2-year follow-up period, 67 (10.1%) individuals without sarcopenia at baseline developed sarcopenia. There were no significant associations between baseline serum GDF-15 levels and incident sarcopenia or its components (all p > .05). CONCLUSIONS: Elevated GDF-15 was associated with prevalent sarcopenia but not able to predict incident sarcopenia in the 2-year follow-up. Further studies are needed to explore the pathophysiological roles of GDF-15 in the development of sarcopenia.
引用
- Kim M, Walston JD, Won CW, et al. Associations Between Elevated Growth Differentiation Factor-15 and Sarcopenia Among Community-dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2022. PMID: 34255062. doi:10.1093/gerona/glab201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。